Rapid Therapeutic Science Laboratories Inc 's

• PCHA's Stock Performance relative to its Competitors

Zynerba Pharmaceuticals Inc Share Performance +136.75% This Year

Zynerba Pharmaceuticals Inc Profile Zynerba Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing innovative transdermal cannabinoid therapies. They utilize their proprietary technology to deliver cannabinoid molecules through the skin, providing targeted treatment for various medical conditions. Zynerba Pharmaceuticals aims to provide effective, safe, and convenient therapeutic options for patients in need. More about Zynerba Pharmaceuticals Inc 's Market Share

Lakeshore Biopharma Co Ltd Share Performance -82.63% This Year

Lakeshore Biopharma Co Ltd Profile The company engages in licensing and collaboration agreements to develop and commercialize product candidates. More about Lakeshore Biopharma Co Ltd's Market Share

Pasithea Therapeutics Corp Share Performance +2.70% Over The Past 5 Days

Pasithea Therapeutics Corp Profile Pasithea Therapeutics Corp's business model revolves around the development and commercialization of therapeutic treatments for sleep disorders and other related conditions. More about Pasithea Therapeutics Corp 's Market Share

Indivior Pharmaceuticals Inc Share Performance -1.93% This Year

Indivior Pharmaceuticals Inc Profile The company develops, markets, and sells pharmaceutical products. More about Indivior Pharmaceuticals Inc 's Market Share

Intelgenx Technologies Corp Share Performance +18.84% One Year

Intelgenx Technologies Corp Profile Intelgenx Technologies Corp is a pharmaceutical company that focuses on developing and manufacturing innovative drug delivery solutions through collaboration with global pharmaceutical partners. Their business model revolves around licensing their advanced oral film technology, VersaFilm, to these partners for the development and commercialization of their own pharmaceutical products. More about Intelgenx Technologies Corp 's Market Share

Sources: Rapid Therapeutic Science Laboratories Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 4, 2026 5:22 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Rapid Therapeutic Science Laboratories Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.